Knock-out-Zertifikate finden
Nähere Informationen zum Handelssegment EASY EUWAX finden Sie hier.
► Tipp: Abonnieren Sie unsere Newsletter, um immer auf dem Laufenden bei aktuellen Wertpapierentwicklungen zu bleiben.
Ihre Auswahl:
33 Ergebnisse
| MB80XF |  | BeiGene Ltd. (ADRs)/KO/Call [endlos]/MS | - | - | call | BeiGene Ltd. (ADRs) | 120,628 | 132,700 | 1,622 | 58,098 % | - | Morgan Stanley | |
| MD2MNN | | BeiGene Ltd. (ADRs)/KO/Call [endlos]/MS | - | - | call | BeiGene Ltd. (ADRs) | 140,087 | 140,087 | 1,797 | 55,765 % | - | Morgan Stanley | |
| MD328F | | BeiGene Ltd. (ADRs)/Faktor/Long [3]/MS | - | - | call | BeiGene Ltd. (ADRs) | 207,088 | 207,088 | 2,878 | 34,609 % | - | Morgan Stanley | |
| MG22CE | | BeiGene Ltd. (ADRs)/KO/Call [endlos]/MS | - | - | call | BeiGene Ltd. (ADRs) | 122,733 | 122,733 | 1,633 | 61,245 % | - | Morgan Stanley | |
| MG34NZ | | BeiGene Ltd. (ADRs)/Faktor/Long [5]/MS | - | - | call | BeiGene Ltd. (ADRs) | 248,516 | 248,516 | 4,704 | 21,527 % | - | Morgan Stanley | |
| MG7KE7 | | BeiGene Ltd. (ADRs)/KO/Call [endlos]/MS | - | - | call | BeiGene Ltd. (ADRs) | 152,086 | 167,300 | 1,937 | 47,172 % | - | Morgan Stanley | |
| MG7XKN | | BeiGene Ltd. (ADRs)/KO/Call [endlos]/MS | - | - | call | BeiGene Ltd. (ADRs) | 162,638 | 178,910 | 2,076 | 43,506 % | - | Morgan Stanley | |
| MG9FVK | | BeiGene Ltd. (ADRs)/KO/Call [endlos]/MS | - | - | call | BeiGene Ltd. (ADRs) | 172,487 | 189,740 | 2,220 | 40,087 % | - | Morgan Stanley | |
| MG9FWP | | BeiGene Ltd. (ADRs)/KO/Call [endlos]/MS | - | - | call | BeiGene Ltd. (ADRs) | 189,736 | 189,736 | 2,519 | 40,088 % | - | Morgan Stanley | |
| MJ8CFY | | BeiGene Ltd. (ADRs)/KO/Call [endlos]/MS | - | - | call | BeiGene Ltd. (ADRs) | 205,114 | 205,114 | 2,880 | 35,232 % | - | Morgan Stanley | |
| MJ8U9Z | | BeiGene Ltd. (ADRs)/KO/Call [endlos]/MS | - | - | call | BeiGene Ltd. (ADRs) | 186,149 | 204,770 | 2,372 | 35,341 % | - | Morgan Stanley | |
| MJ8V0F | | BeiGene Ltd. (ADRs)/KO/Call [endlos]/MS | - | - | call | BeiGene Ltd. (ADRs) | 216,140 | 216,140 | 3,202 | 31,750 % | - | Morgan Stanley | |
| MK1TWC | | BeiGene Ltd. (ADRs)/KO/Call [endlos]/MS | - | - | call | BeiGene Ltd. (ADRs) | 180,144 | 180,144 | 2,321 | 43,116 % | - | Morgan Stanley | |
| MK6WXM | | BeiGene Ltd. (ADRs)/KO/Call [endlos]/MS | - | - | call | BeiGene Ltd. (ADRs) | 201,224 | 221,350 | 2,794 | 30,105 % | - | Morgan Stanley | |
| MK6X8Z | | BeiGene Ltd. (ADRs)/KO/Call [endlos]/MS | - | - | call | BeiGene Ltd. (ADRs) | 232,414 | 232,414 | 3,784 | 26,612 % | - | Morgan Stanley | |
| MK7AJZ | | BeiGene Ltd. (ADRs)/KO/Call [endlos]/MS | - | - | call | BeiGene Ltd. (ADRs) | 220,968 | 243,070 | 3,394 | 23,247 % | - | Morgan Stanley | |
| MK7QDV | | BeiGene Ltd. (ADRs)/KO/Call [endlos]/MS | - | - | call | BeiGene Ltd. (ADRs) | 253,681 | 253,681 | 5,153 | 19,896 % | - | Morgan Stanley | |
| MK7ZT1 | | BeiGene Ltd. (ADRs)/KO/Call [endlos]/MS | - | - | call | BeiGene Ltd. (ADRs) | 230,223 | 253,250 | 3,784 | 20,032 % | - | Morgan Stanley | |
| MM0WK3 | | BeiGene Ltd. (ADRs)/Faktor/Short [3]/MS | - | - | put | BeiGene Ltd. (ADRs) | 414,090 | 414,090 | 3,019 | 30,755 % | - | Morgan Stanley | |
| MM1Z6H | | BeiGene Ltd. (ADRs)/Faktor/Short [4]/MS | - | - | put | BeiGene Ltd. (ADRs) | 388,209 | 388,209 | 4,018 | 22,583 % | - | Morgan Stanley | |
| MM2KYV | | BeiGene Ltd. (ADRs)/KO/Put [endlos]/MS | - | - | put | BeiGene Ltd. (ADRs) | 397,472 | 397,472 | 3,892 | 25,508 % | - | Morgan Stanley | |
| MM4E53 | | BeiGene Ltd. (ADRs)/Faktor/Short [5]/MS | - | - | put | BeiGene Ltd. (ADRs) | 372,681 | 372,681 | 4,994 | 17,680 % | - | Morgan Stanley | |
| MN337Y | | BeiGene Ltd. (ADRs)/Faktor/Short [2]/MS | - | - | put | BeiGene Ltd. (ADRs) | 465,851 | 465,851 | 2,006 | 47,100 % | - | Morgan Stanley | |
| MN8NH1 | | BeiGene Ltd. (ADRs)/Faktor/Short [8]/MS | - | - | put | BeiGene Ltd. (ADRs) | 349,388 | 349,388 | - | 10,325 % | - | Morgan Stanley | |
| MN8NH2 | | BeiGene Ltd. (ADRs)/Faktor/Short [10]/MS | - | - | put | BeiGene Ltd. (ADRs) | 341,624 | 341,624 | - | 7,873 % | - | Morgan Stanley | |
| MN8NK4 | | BeiGene Ltd. (ADRs)/Faktor/Long [8]/MS | - | - | call | BeiGene Ltd. (ADRs) | 271,814 | 271,814 | - | 14,170 % | - | Morgan Stanley | |
| MN8NK5 | | BeiGene Ltd. (ADRs)/Faktor/Long [10]/MS | - | - | call | BeiGene Ltd. (ADRs) | 279,580 | 279,580 | - | 11,718 % | - | Morgan Stanley | |
| MN95UH | | BeiGene Ltd. (ADRs)/Faktor/Long [2]/MS | - | - | call | BeiGene Ltd. (ADRs) | 155,322 | 155,322 | - | 50,954 % | - | Morgan Stanley | |
| MR101N | | BeiGene Ltd. (ADRs)/Faktor/Long [5]/MS | - | - | call | BeiGene Ltd. (ADRs) | 248,516 | 248,516 | - | 21,527 % | - | Morgan Stanley | |
| MR1FCB | | BeiGene Ltd. (ADRs)/Faktor/Long [3]/MS | - | - | call | BeiGene Ltd. (ADRs) | 207,097 | 207,097 | - | 34,606 % | - | Morgan Stanley | |
| MR1FCC | | BeiGene Ltd. (ADRs)/Faktor/Long [4]/MS | - | - | call | BeiGene Ltd. (ADRs) | 232,984 | 232,984 | - | 26,432 % | - | Morgan Stanley | |
| MR2QPY | | BeiGene Ltd. (ADRs)/KO/Call [endlos]/MS | - | - | call | BeiGene Ltd. (ADRs) | 251,129 | 276,250 | 5,073 | 12,770 % | - | Morgan Stanley | |
| MR2QXQ | | BeiGene Ltd. (ADRs)/KO/Call [endlos]/MS | - | - | call | BeiGene Ltd. (ADRs) | 276,242 | 276,242 | 6,954 | 12,772 % | - | Morgan Stanley |